高支出クローン病患者の早期特定のための機械学習フレームワーク:レセプト請求データを利用して
Lukasz S Wylezinski1, Jamieson D Gray1, Charles F Spurlock2,3,4,5
1Decode Health Inc, Nashville, Tennessee, USA.
BMJ health & care informatics
|February 27, 2026
まとめ
機械学習モデルは、クローン病(CD)患者の高い医療費を予測できます。これにより、コストを管理し、患者ケアを改善するための積極的な介入が可能になります。
科学分野:
- 健康情報学; 機械学習の応用; 消化器病学
背景:
- クローン病(CD)は、高い医療費と関連しています。高コスト患者の正確な予測は、リソースの割り当てと介入戦略にとって非常に重要です。
研究 の 目的:
- 医療費の上位四分位層に属するCD患者を予測するための機械学習(ML)モデルを開発および評価すること。従来の予測方法と比較して、MLモデルの予測精度とリードタイムを評価すること。
主な方法:
- 約267,000人のメンバー(CD患者994人を含む)の、匿名化された民間レセプト請求データ(2016年から2018年)を使用しました。支出、人口統計、診断、処置、および薬剤コードを含む月次患者データを集計しました。クロスバリデーションを使用して7つのMLアルゴリズムファミリーを調整し、高コスト支出を予測する能力を将来的にテストしました。
主要な成果:
- 機械学習モデルは、上位四分位層のメンバーによる支出の80%を予測し、ベースラインの過去の方法(67%および62%)を大幅に上回りました。4ヶ月の過去の方法と比較して、毎月新規の高コスト患者をほぼ2倍特定しました。機械学習モデルは、過剰なコストを引き起こす入院患者の遭遇を予測する上でより高い精度を示しました。
結論:
- レセプト請求データに基づく機械学習モデルは、支払者および臨床医が患者管理を最適化し、緊急入院を削減する可能性のある貴重なリードタイムを提供します。標準的なレセプト請求データを使用したこの機械学習フレームワークは、支出に大きなばらつきがある他の状態での高コスト予測にも適応可能です。将来的な検証により、機械学習モデルが、高コストのCD患者を特定するための短期的なリスク層別化を強化することが確認されました。
関連する概念動画
Classification of Illness
9.1K
The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
9.1K
Health Information Technology and Healthcare Information System
3.5K
Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
3.5K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
608
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
608
Inflammatory Bowel Disease II: Crohn's Disease
1.4K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.4K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
974
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
974
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
660
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
660

